#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Selective polysaccharide antibody deficiency Enteritis Anal cancer recurrent Penile squamous cell carcinoma Urethral valves Leber's congenital amaurosis Nephropathy Arterial disorder Small intestine neuroendocrine tumour Renal cancer metastatic Interstitial lung disease Spinal muscular atrophy Transitional cell carcinoma Stargardt's disease Juvenile psoriatic arthritis More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I – Diagnostics Rhabdoid tumour – Basic Information Alagille syndrome – Trials in Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Treatment Glycogen storage disease type V – Treatment Haemophilia B with anti factor IX – Treatment Rhabdomyosarcoma recurrent – Trials in Disease Behcet’s syndrome – Treatment Nephroblastoma – Basic Information Sjogren’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nazartinib Fostemsavir Nms-03305293 SIPAVIBART AAV9-CTNT-COBAG3 Sotagliflozin Adrc ACETYLCARNITINE HYDROCHLORIDE ABBV-8736 Thiopental Sodium Dexchlorpheniramine GSKVX000000040033 Ascorbic Acid Mps-106 Osilodrostat 4-Hydroxy-N-Desmethyltamoxifen Deflazacort Ly3556050 Dosulepin Hydrochloride Thiamine Nitrate More therapies…

    Learn about Your Condition

    Hyperkalaemia Propionic acidaemia Cervix carcinoma stage IV Toxic epidermal necrolysis Febrile neutropenia Metabolic disorder Uterine cancer Haemofiltration Abortion threatened Anogenital warts Cleft lip and palate Hypercholesterolaemia Lip and/or oral cavity cancer Naevus flammeus Mitral valve prolapse More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on the Safety and Effectiveness of OD-07656 and Vedolizumab for Patients with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Vedolizumab
    Austria Belgium Croatia Czechia Hungary Lithuania +1

  • Study on BI 3032950 for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Bi 3032950
    Belgium Czechia Poland Slovakia

  • Study on Ulcerative Colitis: Effects of Filgotinib and Gallium (68Ga) Chloride in Patients with Intestinal Fibrosis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Gallium (68Ga) Chloride
    The Netherlands

  • A study to evaluate the effectiveness and safety of tulisokibart and placebo in patients with moderate to severe ulcerative colitis

    Not recruiting

    3 1
    Investigated Drugs:
    • Tulisokibart
    Austria Belgium Bulgaria Croatia Czechia Finland +15

  • Study of linaprazan glurate and lansoprazole to maintain healing in patients with erosive esophagitis caused by acid reflux disease

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Lansoprazole
    • LINAPRAZAN GLURATE
    Bulgaria Czechia Germany Hungary Poland Romania

  • A study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Vixarelimab
    • Adalimumab
    • Azathioprine
    Belgium Czechia France Germany Greece Italy +1
Previous Page
1 … 57 58 59 60 61 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!